Clinical trial
Impact of Transcatheter Aortic Valve Implantation on the Composition and Function of the Gut Microbiota
NCT07565077 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Transcatheter Aortic Valve Implantation on the Composition and Function of the Gut Microbiota
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 1, 2024
- Completion date
- February 28, 2029
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
calcific aortic valve disease, dysbiosis, inflammation, tavi